Similar Items: Identification of genetically predicted protein biomarkers and drug targets for prostate cancer via Mendelian randomization
- Back Cover: Identification of genetically predicted protein biomarkers and drug targets for prostate cancer via Mendelian randomization (View 3/2026)
- Protein modification systems as cancer biomarkers and therapeutic targets
- Identifying genetics biomarkers in correlation with pathological and PSMA PET/CT characteristics in prostate cancer
- Targeted proteomics for the detection of androgen receptor variants in preclinical models of castration-resistant prostate cancer
- Repurposing the liquid-based Pap test for the detection of ovarian cancer protein biomarkers
- Cancer stem cells and drug resistance in cancer: molecular mechanisms and therapeutic targets